Latest Breaking News On - Frank mcenulty - Page 1 : vimarsana.com

Cell MedX Corp Appoints Mr Dwayne Yaretz as CEO and Director

Cell MedX Corp Appoints Mr Dwayne Yaretz as CEO and Director
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDwayne yaretzFrank mcenultyExchange commissionHealth canadaNevada newsfile corpCell medx corpCompany quarterlyBoard of directors cell medx corpWall streetChief executiveCorporate secretaryCell medxIpro systemsHealth canada approvalDevice systems

Cell MedX Corp Files Premarket Notification (510K) with the US Food and Drug Administration and Receives Canadian Trademark

Cell MedX Corp Files Premarket Notification (510K) with the US Food and Drug Administration and Receives Canadian Trademark
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesFrank mcenultyTrademark office onDrug administrationNevada newsfile corpCell medx corpBoard of directors cell medx corpExchange commissionHealth canadaCanadian intellectual property officeCompany quarterlyCarson cityHome systemPro systemUnited states patentTrademark office

Cell MedX Corp Converts Debt to Shares, Closes Non-Brokered Private Placement Financing, and Engages Investor Relations Consultants

(1) Carson City, Nevada (Newsfile Corp. - May 26, 2021) - Cell MedX Corp. (OTCQB: CMXC) ( Cell MedX or the Company ), a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general health and wellness, is pleased to announce that on May 25, 2021, the Company issued 2,484,500 common shares of the Company (the Shares ) on conversion of $496,900 the Company owed its debt holders under 6% demand notes payable and non-interest-bearing advances. In addition to issuance of the shares, the Debt holders agreed to forgive $32,677 in accrued interest. Concurrently with conversion of debt, the Company closed a non-brokered private placement financing at a price of $0.20 per Share, by issuing 200,000 Shares for total gross proceeds of $40,000.

United statesHoward isaacsFrank mcenultyRichard cavalliJim macfarlaneExchange commissionNevada newsfile corpCell medx corpCompany theCompany quarterlyBoard of directors cell medx corpCarson cityUnited states securities actCell medxGriffith armada capitalCurrent reports